WHO mulls over labeling obesity drugs as essential medicines
A request to consider a Novo Nordisk obesity drug as an essential medicine was submitted by three doctors and a scientist in the US.
by marketwire, translated by daniel pedersen
Medicines that aid weight loss could potentially find themselves, for the first time, on the World Health Organization’s list over essential medicines, which is used to guide purchasing decisions in low- and middle-income countries, reports Reuters.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
